Literature DB >> 15634226

The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes.

W F Blakemore1.   

Abstract

In certain experimental and naturally occurring pathological situations in the central nervous system (CNS), demyelinated axons are remyelinated by Schwann cells. It has always been assumed that these Schwann cells are derived from Schwann cells associated with peripheral nerves. However, it has become apparent that CNS precursors can give rise to Schwann cells in vitro and following transplantation into astrocyte-free areas of demyelination in vivo. This paper compares the behaviour of remyelinating Schwann cells following transplantation of peripheral nerve derived Schwann cells over, and into, astrocyte-depleted areas of demyelination to that which follows transplantation of CNS cells and that seen in normally remyelinating ethidium bromide induced demyelinating lesions. It concludes that while the examination of normally remyelinating lesions can not resolve the origin of the remyelinating Schwann cells, the results from transplantation studies provide strong evidence that the Schwann cells that remyelinate CNS axons are most likely generated from CNS precursors. In addition these studies also indicate that the precursors that give rise to these Schwann cells are the same cells that give rise to remyelinating oligodendrocytes.

Entities:  

Mesh:

Year:  2005        PMID: 15634226     DOI: 10.1111/j.1365-2990.2005.00637.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  21 in total

1.  CNS Schwann cells display oligodendrocyte precursor-like potassium channel activation and antigenic expression in vitro.

Authors:  Kristel Kegler; Ilka Imbschweiler; Reiner Ulrich; Peter Kovermann; Christoph Fahlke; Ulrich Deschl; Arno Kalkuhl; Wolfgang Baumgärnter; Konstantin Wewetzer
Journal:  J Neural Transm (Vienna)       Date:  2014-02-01       Impact factor: 3.575

Review 2.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

3.  Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent.

Authors:  Jason F Talbott; Qilin Cao; Gaby U Enzmann; Richard L Benton; Virginie Achim; Xiao X Cheng; Michael D Mills; Mahendra S Rao; Scott R Whittemore
Journal:  Glia       Date:  2006-08-15       Impact factor: 7.452

Review 4.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

5.  Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats.

Authors:  Nai-Kui Liu; William Lee Titsworth; Yi Ping Zhang; Aurela I Xhafa; Christopher B Shields; Xiao-Ming Xu
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

6.  Nitric oxide signaling and neural stem cell differentiation in peripheral nerve regeneration.

Authors:  Jessica Tao Li; Chandra Somasundaram; Ka Bian; Weijun Xiong; Faiz Mahmooduddin; Rahul K Nath; Ferid Murad
Journal:  Eplasty       Date:  2010-06-14

7.  Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.

Authors:  Daniella Urbach-Ross; Alexander W Kusnecov
Journal:  Brain Behav Immun       Date:  2007-05-08       Impact factor: 7.217

8.  Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord.

Authors:  Nicholas J Kuypers; Kurtis T James; Gaby U Enzmann; David S K Magnuson; Scott R Whittemore
Journal:  Exp Neurol       Date:  2013-03-04       Impact factor: 5.330

9.  Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain.

Authors:  Nitish Kumar; Nidhi Sharma; Rishabh Khera; Ria Gupta; Sidharth Mehan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

10.  Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.

Authors:  Kristel Kegler; Ingo Spitzbarth; Ilka Imbschweiler; Konstantin Wewetzer; Wolfgang Baumgärtner; Frauke Seehusen
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.